An innovative company dedicated to liver health

Our vision & our mission

We are shaping the future of liver health.

We are empowering medical professionals to manage liver health for simpler,
faster and better patient care.

More about echosens

317

employees over eight subsidiaries

distributors over the world

125

international patents granted

12%

of annual sales invested in product development

*Discover Echosens and our commitment for liver health in video*

Corporate Brochure

chevron — *Discover Echosens and our commitment for liver health in video*

Corporate Brochure

It’s about passionate and humble people that make us see simplicity out of complexity.
Before becoming a company, echosens was an idea. This idea has been growing from its root in Paris, within Prof. Fink’s lab. Initially, my PhD thesis paved the way for the development of transient elastography (TE), which we patented in 1999.

> 20 years of liver health – Continue the story

Laurent Sandrin | Founder and Chief Technology Officer at Echosens

Based on our values, Echosens is committed to achieving the Sustainable Development Goals

Echosens has been awarded the gold medal, ranking in the top 5% of over 100,000 companies assessed in 200 industries and 175 countries. The overall EcoVadis score obtained reflects the quality of the company’s ESG program.

c Courage

h Humility

o Openness

i Innovation

c Commitment

e Environment

s Simplicity

Discover our ESG program

Key dates

Inception in Paris

After Laurent Sandrin’s PhD thesis on transient elastography (TE), this technology found its application to quantify liver stiffness (LSM by VCTE™) allowing a better patient care in hepatology…

First accomplishment: FibroScan^® is born

The very first FibroScan^®launched on the market is the FibroScan^® 502. It was released during the EASL Congress in Geneva.

CAP™ parameter

In addition to VCTE™, Echosens introduced a new, unique and patented technology called CAP™ (Controlled Attenuation Parameter) for liver steatosis assessment, a true benefit to measure patient’s liver fat.

FibroScan^® mobile generation

With FibroScan^® Mini+ 430 and FibroScan^®Compact 530, the FibroScan^®family evolves to better fit physicians daily practice with mobility, user-friendliness and connectivity, ideal for multi-site configuration.